BULLSEYE BIOSCIENCES, INC.
Bullseye Biosciences develops novel therapeutics by evolving proteins to address hard-to-treat human diseases. The company applies directed evolution combined with laboratory automation, next-generation sequencing, and artificial intelligence to discover and optimize drug candidates. Bullseye operates as a biotechnology drug-discovery firm serving biopharma and healthcare organizations through discovery-stage partnerships and programs. Its focus areas include cardiometabolic diseases, inflammation, and oncology, targeting indications with high unmet medical need.
BULLSEYE BIOSCIENCES, INC.
Bullseye Biosciences develops novel therapeutics by evolving proteins to address hard-to-treat human diseases. The company applies directed evolution combined with laboratory automation, next-generation sequencing, and artificial intelligence to discover and optimize drug candidates. Bullseye operates as a biotechnology drug-discovery firm serving biopharma and healthcare organizations through discovery-stage partnerships and programs. Its focus areas include cardiometabolic diseases, inflammation, and oncology, targeting indications with high unmet medical need.